Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.84B 3.12B 2.79B 2.57B 2.34B 4.38B 296B 4.45B 30.97B 12.2B 155B 11.72B 11.47B 491B P/E 2026 *
14x
P/E 2027 * 12.2x
Enterprise Value 17.5B 2.62B 2.34B 2.16B 1.96B 3.68B 248B 3.74B 26.01B 10.24B 130B 9.84B 9.63B 412B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.53x
Free-Float
34.77%
Yield 2026 *
5.15%
Yield 2027 * 5.7%
1 day+1.22%
1 week-3.63%
Current month+0.55%
1 month+1.95%
3 months-3.23%
6 months+2.98%
Current year+3.86%
1 week 17.74
Extreme 17.74
19.38
1 month 17.32
Extreme 17.32
19.48
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 2013-07-15
Director/Board Member 63 2016-08-07
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-3.63%-1.98%-20.88% 3.08B
-2.42%+2.26%-40.89%+7.59% 15.82B
+11.66%-0.49%+7.45%-21.13% 7.35B
-0.14%+3.71%-15.18%+3.63% 6.27B
+1.92%+6.15%-9.15%+2.56% 6.41B
-3.07%-1.04%-53.59%-36.78% 6.05B
+0.08%+0.87%+2.15%-3.78% 4.65B
-2.12%+1.98%-35.09%+1.60% 3.45B
+0.02%+1.46%-14.06%-11.34% 3.17B
-2.51%-1.39%-28.77%-38.29% 3.04B
Average +0.46%+2.19%-18.91%-11.68% 5.93B
Weighted average by Cap. +0.50%+3.09%-22.25%-7.54%

Financials

2026 *2027 *
Net sales 29.54B 4.42B 3.95B 3.64B 3.31B 6.21B 419B 6.31B 43.9B 17.29B 220B 16.61B 16.25B 696B 32.52B 4.87B 4.35B 4.01B 3.64B 6.84B 461B 6.94B 48.33B 19.04B 242B 18.29B 17.89B 766B
Net income 1.49B 223M 199M 183M 167M 312M 21.08B 317M 2.21B 870M 11.05B 835M 818M 34.99B 1.71B 256M 229M 211M 192M 360M 24.28B 365M 2.54B 1B 12.72B 962M 942M 40.3B
Net Debt -3.34B -500M -447M -412M -374M -702M -47.39B -713M -4.96B -1.96B -24.83B -1.88B -1.84B -78.66B -3.76B -563M -503M -464M -421M -791M -53.35B -803M -5.59B -2.2B -27.95B -2.11B -2.07B -88.55B
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-10-21 CN¥18.30 +1.22% 13,743,420
26-10-21 CN¥18.08 -0.93% 13,258,422
26-10-20 CN¥18.25 -4.30% 30,389,421
26-10-19 CN¥19.07 +2.47% 16,165,080
26-10-16 CN¥18.61 -0.69% 11,084,185
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.30CNY
Average target price
23.75CNY
Spread / Average Target
+29.78%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock